Gestione del paziente con STEMI e senza STEMI - · PDF fileLE NUOVE LINEE GUIDA 2015 ......

Post on 06-Feb-2018

232 views 5 download

Transcript of Gestione del paziente con STEMI e senza STEMI - · PDF fileLE NUOVE LINEE GUIDA 2015 ......

LE NUOVE LINEE GUIDA 2015

DELLA RIANIMAZIONE CARDIOPOLMONARE

Gestione del paziente con

STEMI e senza STEMI

Luisa Cacciavillani U.C.I.C. Clinica Cardiologica.

Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari.

Università degli Studi di Padova

Troponina: necessaria, ma non sufficiente!

CHEST PAIN

ECG bedside

STEMI

Emergency

Department

CHEST PAIN

ECG bedside

STEMI

Emergency

Department

STEMI

European Heart Journal (2012) 33, 2569–2619

European Heart Journal (2012) 33, 2569–2619

Reperfusion therapy is indicated in all patients

with symptoms of <12 h duration and persistent

ST-segment elevation

Primary PCI is the recommended reperfusion

therapy if performed by an experienced team

within 120 min of FMC.

STEMIReperfusion therapy

FIBRINOLYTIC THERAPY

European Heart Journal (2012) 33, 2569–2619

STEMI

European Heart Journal (2012) 33, 2569–2619

LATECOMERS

>72 ore dall'inizio dei sintomi

EARLY LATECOMERS

Am J Cardiol 2012; 110: 1275-1281

12-72 ore dall'inizio dei sintomi

PCI PRIMARIA

PCI PRIMARIA

CULPRIT ONLY?

• There is no current evidence to support emergency

intervention in non-infarct-related lesions.

• The only exceptions, when multivessel PCI duringacute STEMI is justified, are:

patients with cardiogenic shock if there is persistent ischaemia after PCI of the

supposed culprit lesion.

PCI PRIMARIA

NEJM 2013; 369: 1115-1123

Culprit onlyvs

Immediata MV PCI

JACC 2015; 65 (10): 963-972

Culprit onlyvs

Immediata MV PCI o staged MV PCI

CULPRIT ONLY?

PCI PRIMARIA

NEJM 2013; 369: 1115-1123

Culprit onlyvs

Immediata MV PCI

PCI PRIMARIACULPRIT ONLY?

PCI PRIMARIACULPRIT ONLY?

ESC linee guida NSTEMI 2015

antiplatelet therapy

antiplatelet therapy

Anticoagulant therapy

STEMIASA : 150 mg i.v., followed by a maintenance dose

of 100 mg/day

PRASUGREL: loading dose of 60 mg orally, followed by a maintenance dose of 10 mg/day

CATH-LAB

UNFRACTIONATED HEPARIN: 70–100U/kg i.v.bolus

Long-term therapy

Logistical issue for hospital stay

Length of stay

CHEST PAIN

ECG bedside

NSTEMI

Emergency

Department

NSTEMI

Hs-c Tn 0h/3h algorithm

RISK STARTIFICATION

NSTEMI

RISK STARTIFICATION

NSTEMI

•diabetes mellitus•renal insufficiency•LVEF < 40•early post-infarction angina•recent PCI•prior CABG•known ischaemia on non-invasive testing

antiplatelet therapy

Antiplatelet and oral anticoagulation